Henry Featherstone
Head of Health Unit, 2008-2010
Henry now leads public affairs activity in the UK & Ireland for Genzyme Therapeutics, a leading bio-pharmaceutical company and part of the Sanofi Group.
Related Publications
All Together Now: Competitive integration in the NHS
Perverse incentives in NHS funding structures have greatly increased the number of unnecessary admissions to hospitals over the last ten years by failing to encourage GPs and consultants to work together in the best interests of the patient. The NHS pay and performance system needs to move away from considering each of their professional groups as an isolated case and encourage them to work together.
Incentivising Wellness: Improving the treatment of long-term conditions
Incentivising Wellness shows how the NHS can save tens of billions of pounds while also taking better care of one of the UK’s fastest-growing diseases – diabetes.
Careless: Funding long-term care for the elderly
Careless argues that introducing free personal care funded by general taxation is far too expensive. The report instead recommends that three specific funding models be considered by the Coalition's Commission on the funding of care and support long-term.
Cough Up: Balancing tobacco income and costs in society
It is a popular myth that smoking is a net contributor to the economy – our research finds that every single cigarette smoked costs the country 6.5 pence. In order to balance income and costs, tobacco duty should be progressively increased until the full societal cost of smoking is met through taxation.
Future Foundations: Towards a new culture in the NHS
The report argues that the continuing obsession at the top of Government with ‘being seen to do something’ means that ministers think and act if they were responsible for almost all significant operational decisions, in effect undermining the independence that was at the heart of creating Foundation Trusts.
The Cost of Cancer
The report highlights late diagnosis, poor survival rates for older people and those in deprived communities, and relatively poor take up of new treatments and technologies as being the most likely causes behind the UK’s comparatively high mortality rate for cancer patients.
Controlling Public Spending: The NHS in a period of tight funding
Our research, which included a roundtable discussion with a number of senior academics and business leaders with expertise in the NHS, considers some of the options for the NHS in a period of tight funding.
Which Doctor? Putting patients in control of primary care
Which Doctor? proposes a radical new framework to tackle the inequality of primary health care provision. The proposals recommend that the majority of NHS funding (£84.4 billion in 2010–11) be distributed on the basis of a patients’ age and postcodes, and that GPs be financially incentivised to set up practices in areas of most need through a ‘patient premium’.